A big pharma brand needed a deeper understanding of the AL Amyloidosis journey from the patient perspective, mapped out by key steps and milestones. They wanted to uncover any opportunities by identifying the white space in the current market and ways to make a difference to patients’ lives.
Additionally, they wanted the results to be compared and contrasted with studies by physicians, to identify potential gaps and differences.
Want to learn more about this project?
Our global insights team conducts social listening in over 70 languages to answer our clients’ most important business questions with actionable insights that deliver impact.